IMMUNIC, INC. — Director's Dealing 2014

Apr 23, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2014-04-23

Reporting Person: Winters Terence E. (Director, Co-Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-04-23	Common Stock	C	122964	—	Acquired	123204	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-04-23	Convertible Preferred Stock	$	C	116714	Disposed		Common Stock (116714)	Indirect
2014-04-23	Senior Convertible Preferred Stock	$	C	6250	Disposed		Common Stock (6250)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	59878	Direct
Common Stock	240	Indirect

Footnotes

F1: Upon the consummation of the Registrant's initial public offering, each fractional share of Common and Convertible Preferred Stock was automatically rounded up to the nearest whole share.

F2: Each share of Convertible Preferred Stock automatically converted into the Registrant's common stock on a one-for-one basis immediately prior to the closing of the Registrant's initial public offering and had no expiration date.

F3: Each share of Senior Convertible Preferred Stock automatically converted into the Registrant's common stock on a one-for-one basis immediately prior to the closing of the Registrant's initial public offering and had no expiration date.